Q8TEK3 (DOT1L_HUMAN) Homo sapiens (Human)
Histone-lysine N-methyltransferase, H3 lysine-79 specific UniProtKBInterProSTRINGInteractive Modelling
1537 aa; Sequence (Fasta) ; (Isoform 1)
It is possible new templates exist for this target since these models were created.
Available Structures
48 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Active state Dot1L bound to the H2B-Ubiquitinated nucleosome, 2-to-1 complex |
Heteromer P02281; P06897; P0CG47; P62799; P84233; | 100 | 2×SAM; | |||
| Cryo-EM structure of Dot1L and H2BK34ub-H3K79Nle nucleosome 1:1 complex |
Heteromer O60814; P04908; P0CG47; P62805; Q71DI3; | 100 | 1×SAM; | |||
| cryo-EM structure of DOT1L bound to H2B ubiquitinated nucleosome |
Heteromer P02281; P0CG47; P62799; P84233; Q6AZJ8; | 100 | 1×SAM; | |||
| Active state Dot1L bound to the H2B-Ubiquitinated nucleosome, 1-to-1 complex |
Heteromer P02281; P06897; P0CG48; P62799; P84233; | 100 | 1×SAM; | |||
| Structure of Dot1L-H2BK120ub nucleosome complex |
Heteromer F5H388; P02281; P06897; P62799; P84233; | 100 | ||||
| Structure of Dot1L-H2BK34ub Nucleosome Complex |
Heteromer O60814; P04908; P62805; P62979; P68431; | 100 | 1×SAH; | |||
| Dot1L bound to the H2BK120 Ubiquitinated nucleosome |
Heteromer P02281; P06897; P0CG47; P62799; P84233; | 97.87 | 1×SAH; | |||
| Cryo-EM structure of Dot1L and H2BK34ub-H3K79Nle nucleosome 2:1 complex |
Heteromer O60814; P04908; P0CG47; P62805; Q71DI3; | 100 | 2×SAM; | |||
| cryo-EM structure of DOT1L bound to unmodified nucleosome |
Heteromer P02281; P62799; P84233; Q6AZJ8; | 100 | 1×SAM; | |||
| Poised-state Dot1L bound to the H2B-Ubiquitinated nucleosome |
Heteromer J3QS39; P02281; P06897; P62799; P84233; | 92.36 | ||||
| Cryo-EM structure of human DOT1L in complex with an H2B-monoubiquitinated nucleosome |
Heteromer A0A310TTQ1; P02281; P62799; P62979; Q6AZJ8; | 100 | 1×SAH; | |||
| Crystal structure of the coiled-coil domains of human DOT1L in complex with AF10 |
Heteromer P55197; | 100 | ||||
| Crystal structure of AF10-DOT1L complex |
Heteromer Q5JT35; | 100 | ||||
| Solution NMR structure of DOT1L in complex with AF9 (DOT1L-AF9) |
Heteromer P42568; | 100 | ||||
| STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH DOT1L(998-1006) PHOSPHOPEPTIDE |
Heteromer P01889; P61769; | 100 | 1×GLC; | |||
| STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH DOT1L(998-1006) PEPTIDE |
Heteromer P01889; P61769; | 100 | 1×GLC; 1×NA; | |||
| Crystal structure of Dot1L in complex with adenosine and inhibitor CPD1 [N6-(2,6-dichlorophenyl)-N6… | homo-2-mer | 97.56 | 2×ADN; 2×5JJ; 1×TLA; | |||
| Structure-Guided DOT1L Probe Optimization by Label-Free Ligand Displacement | monomer | 96.22 | 1×3US; 3×SO4; 1×GOL; 3×EDO; | |||
| Crystal structure of Dot1l in complex with 5-iodotubercidin | monomer | 100 | 1×5ID; 2×IOD; 1×NA; 6×UNX; | |||
| Crystal Structure of human DOT1L in complex with inhibitor SGC0947 | monomer | 96.17 | 1×AW3; 1×GOL; | |||
| Crystal structure of human DOT1L in complex with inhibitor FED2 | monomer | 98.22 | 1×AW0; 6×UNX; | |||
| Crystal structure of human DOT1L in complex with inhibitor SGC0946 | monomer | 99.11 | 1×BR; 1×AW2; 1×NA; | |||
| Crystal structure of human DOT1L in complex with 2 molecules of EPZ004777 | monomer | 97.34 | 2×0QK; 5×UNX; | |||
| Crystal Structure of human DOT1L in complex with inhibitor FED1 | monomer | 93.75 | 1×AW1; 3×UNX; | |||
| Crystal Structure of DOT1L in Complex with EPZ-5676 | monomer | 96.68 | 1×EP6; 2×SO4; | |||
| complex of Dot1l with SS148 | monomer | 98.48 | 22×UNX; 1×6NR; | |||
| Crystal structure of Dot1l in complex with a brominated SAH analog | monomer | 98.48 | 1×SX0; 1×SO4; 20×UNX; | |||
| Crystal structure of Dot1L in complex with an inhibitor (compound 3). | monomer | 97.26 | 1×N4W; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD1 [N6-(2,6-dichlorophenyl)-N6-(pent-2-yn-1-… | monomer | 97.26 | 1×5JJ; 1×5JT; 1×TLA; | |||
| Crystal structure of Dot1L in complex with an inhibitor (compound 10). | monomer | 95.12 | 1×N4Z; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD1 [4-(2,6-dichlorobenzoyl)-N-methyl-1H-pyrr… | monomer | 97.26 | 1×5F4; | |||
| Crystal structure of Dot1L in complex with an inhibitor (compound 11). | monomer | 96.95 | 1×N5K; 1×SO4; | |||
| DOT1L structure in complex with SAH | monomer | 99.39 | 1×SAH; 4×SO4; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD5 [N-(2,6-dichlorophenyl)-4-methoxy-N-methy… | monomer | 97.26 | 1×5F7; | |||
| Crystal Structure of Human DOT1L in complex with inhibitor EPZ004777 | monomer | 94.82 | 1×0QK; 5×SO4; 2×EDO; 6×UNX; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD10 [6'-chloro-1,4-dimethyl-5'-(2-methyl-6-(… | monomer | 96.34 | 1×K; 1×5EW; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD3 [N-(1-(2-chlorophenyl)-1H-indol-6-yl)-2-(… | monomer | 97.26 | 1×K; 1×5EK; | |||
| Crystal Structure of Human DOT1L in Complex with a Selective Inhibitor | monomer | 100 | 1×TT8; 1×GOL; 1×ACT; 1×SO4; | |||
| Structure of the Catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransf… | monomer | 100 | 1×ACT; 2×SO4; 1×SAM; | |||
| Crystal structure of DOT1L in complex with EPZ000004 | monomer | 99.08 | 1×EP4; 2×SO4; 1×GOL; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD3 [(2,6-dichlorophenyl)(quinolin-6-yl)metha… | monomer | 97.56 | 1×5F6; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD2 [2-(2-(5-((2-chlorophenoxy)methyl)-1H-tet… | monomer | 95.73 | 1×5EG; | |||
| DOT1L Structure in complex with SAM | monomer | 98.47 | 1×SAM; 2×SO4; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD7 [N-(3-(((R)-1-(7H-pyrrolo[2,3-d]pyrimidin… | monomer | 93.27 | 1×5JU; 2×SO4; | |||
| Crystal structure of Dot1L in complex with inhibitor CPD11 [N4-methyl-N2-(2-methyl-1-(2-phenoxyphen… | monomer | 95.11 | 1×5EV; 2×SO4; | |||
| Crystal Structure of DOT1L in Complex with EPZ003696 | monomer | 97.55 | 1×0QJ; | |||
| Crystal Structure of DOT1L in complex with EPZ004777 | monomer | 97.55 | 1×0QK; 3×SO4; | |||
| Crystal structure of DOT1L in complex with 18-Crown-6 | monomer | 96.63 | 1×O4B; 1×SAH; 5×SO4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3uwp.1.A | monomer | 0.78 | 1×5ID; | 100.00 | ||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 1 | 3uwp.1.A | monomer | 0.78 | 1×5ID; | 100.00 | ||